The role of diastolic blood pressure when treating isolated systolic hypertension

被引:237
作者
Somes, GW [1 ]
Pahor, M [1 ]
Shorr, RI [1 ]
Cushman, WC [1 ]
Applegate, WB [1 ]
机构
[1] Univ Tennessee, Dept Prevent Med, Memphis, TN 38105 USA
关键词
D O I
10.1001/archinte.159.17.2004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess the role of treated diastolic blood pressure (DBP) level in stroke, coronary heart disease (CHD), and cardiovascular disease (CVD) in patients with isolated systolic hypertension (ISH). Design: An analysis of the 4736 participants in the Systolic Hypertension in the Elderly Program (SHEP) was undertaken. The SHEP was a randomized multicenter double-blind outpatient clinical trial of the impact of treating ISH in men and women aged 60 years and older. Main Outcome Measures: Cox proportional hazards regression analysis, with DBP and systolic blood pressure (SBP) as time-dependent covariables. Results: After adjustment for the baseline risk factors of race (black vs other), sex, use of antihypertensive medication before the study, a composite variable (diabetes, previous heart attack, or stroke), age, and smoking history (ever vs never) and adjustment for the SEP as a time-dependent variable, we found, for the active treatment group only, that a decrease of 5 mm Hg in DBP increased the risk for stroke (relative risk, [RR], 1.14; 95% confidence interval [CI], 1.05-1.22),for CHD (RR, 1.08; 95% CI, 1.00-1.16), and for CVD (RR, 1.11; 95% CI, 1.05-1.16). Conclusions: Some patients with ISH may be treated to a level that uncovers subclinical disease, and some may be overtreated. Further studies need to determine whether excessively low DBP can be prevented by more careful titration of antihypertensive therapy while maintaining SEP control. It is reassuring that patients receiving treatment for ISH never perform worse than patients receiving placebo in terms of CVD events.
引用
收藏
页码:2004 / 2009
页数:6
相关论文
共 25 条
[1]   TREATMENT-INDUCED BLOOD-PRESSURE REDUCTION AND THE RISK OF MYOCARDIAL-INFARCTION [J].
ALDERMAN, MH ;
OOI, WL ;
MADHAVAN, S ;
COHEN, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (07) :920-924
[2]  
[Anonymous], 1985, J Hypertens, V3, P379
[3]  
[Anonymous], 1991, JAMA, V265, P3255
[4]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]
[5]   ARTERIAL STIFFNESS - A NEW CARDIOVASCULAR RISK FACTOR [J].
ARNETT, DK ;
EVANS, GW ;
RILEY, WA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (08) :669-682
[6]   Low diastolic blood pressure and atherosclerosis in elderly subjects - The Rotterdam Study [J].
Bots, ML ;
Witteman, JCM ;
Hofman, A ;
deJong, PTVM ;
Grobbee, DE .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (08) :843-848
[7]   RANDOMIZED TRIAL OF TREATMENT OF HYPERTENSION IN ELDERLY PATIENTS IN PRIMARY CARE [J].
COOPE, J ;
WARRENDER, TS .
BRITISH MEDICAL JOURNAL, 1986, 293 (6555) :1145-1151
[8]   THE RELATION BETWEEN DEGREE OF BLOOD-PRESSURE REDUCTION AND MORTALITY AMONG HYPERTENSIVES IN THE HYPERTENSION DETECTION AND FOLLOW-UP PROGRAM [J].
COOPER, SP ;
HARDY, RJ ;
LABARTHE, DR ;
HAWKINS, CM ;
SMITH, EO ;
BLAUFOX, MD ;
COOPER, CJ ;
ENTWISLE, G ;
MAXWELL, MH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 127 (02) :387-403
[9]   CORONARY FLOW RESERVE AND THE J-CURVE RELATION BETWEEN DIASTOLIC BLOOD-PRESSURE AND MYOCARDIAL-INFARCTION [J].
CRUICKSHANK, JM .
BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6658) :1227-1230
[10]  
CRUICKSHANK JM, 1987, LANCET, V1, P581